1 |
Sharifah NA, Seeni A, Nurismah MI, et al (2009). Prevalence of human papillomavirus in abnormal cervical smears in Malaysian patients. Asian Pac J Cancer Prev, 10, 303-6.
|
2 |
Parkin DM, Bray F (2006). Chapter 2: The burden of HPVrelated cancers. Vaccine, 24, 3-11.
DOI
ScienceOn
|
3 |
Bhatla N, Lal N, Bao YP, et al (2008). A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine, 26, 2811-7.
DOI
ScienceOn
|
4 |
Bosch FX, Castellsague X, de Sanjose S (2008). HPV and cervical cancer: screening or vaccination? Br J Cancer, 98, 15-21.
DOI
ScienceOn
|
5 |
National Cancer Registry (NCR), Ministry of Health Malaysia (2011) Malaysia Cancer Statistics Report 2007 - Data and Figure.
|
6 |
Speich N, Schmitt C, Bollmann R, et al (2004). Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the West German area. J Med Microbiol, 53, 125-8.
DOI
ScienceOn
|
7 |
Stoler MH, Wright TC, Jr Sharma A, et al (2011). High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol, 135, 468-75.
DOI
|
8 |
Vu L, Le H, Luong O, et al (2012). Prevalence of cervical human papillomavirus infection among married women in Hanoi, Vietnam. Asia Pac J Public Health, 24, 385-90.
DOI
|
9 |
WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), HPV and cervical cancer statistics in Malaysia. Summary report (2007).
|
10 |
Castlellsague X, Sanjose Sd, T Aguado KSL, et al (2007). HPV and cervical cancer in the world; 2007 report. Vaccine, 25, 130.
|
11 |
Burchell AN, Winer RL, Sanjos'e Sd, et al (2006). Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine, 24, 52-61.
|
12 |
Carter JR, Ding Z, Rose BR (2011). HPV infection and cervical disease: A review. Aust N Z J Obstet Gynaecol, 51, 103-8.
DOI
|
13 |
Casalegno JS, Benchaib M, Le Bail Carval K, et al (2011). Human papillomavirus genotype distribution among French women with and without cervical abnormalities. Int J Gynaecol Obstet, 114, 116-9.
DOI
|
14 |
Clifford G, Franceschi S, Diaz M, et al (2006a). Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine, 24, 26-34.
|
15 |
Clifford GM, Goncalves MA, Franceschi S (2006b). Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS, 20, 2337-44.
DOI
|
16 |
Evans MF, Adamson CS, Papillo JL, et al (2006). Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer, 106, 1054-64.
DOI
ScienceOn
|
17 |
Domingo EJ, Noviani R, Noor MR, et al (2008). Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine, 26, 71-9.
DOI
ScienceOn
|
18 |
Giuliano AR, Lazcano-Ponce E, Villa LL, et al (2008). The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev, 17, 2036-43.
DOI
|
19 |
Janicek MF, Averette HE (2001). Cervical cancer: prevention, diagnosis, and therapeutics. CA Cancer J Clin, 51, 92-114.
DOI
ScienceOn
|
20 |
Boulanger JC, Sevestre H, Bauville E, et al (2004). Epidemiology of HPV infection. Gynecol Obstet Fertil, 32, 218-23.
DOI
|